Frontier
Copyright ©The Author(s) 2021.
World J Gastrointest Surg. Oct 27, 2021; 13(10): 1110-1121
Published online Oct 27, 2021. doi: 10.4240/wjgs.v13.i10.1110
Table 2 Summary of comparative studies: Baseline clinical-pathological features of both treatment groups
Ref.Difference between study groupsICG, %
Child A/B/C, %
Tumor size in cm
Microvascular invasion, %
LLR
OLR
LLR
OLR
LLR
+/- SD/95%CI
OLR
+/- SD/95%CI
LLR
OLR
Belli et al[5]Tumor size, AFP level, margin width91/9/093.6/6.4/03.8+/-1.36+/-2.33739.2
Tranchart et al[6]3.6+/-1.753.7+/-2.133.335.7
Lee et al[7]Cirrhosis, previous abdominal surgery, margin width2.51.5-92.91.2-9
Ahn et al[8]14.513.12.6+/-1.52.8+/-1.215.719.6
Memeo et al[9]Margin width98/2/096/4/03.20.9-113.70.1-15
Lee et al[10]Margin width97.6/2.4/097.6/2.4/05.42-164.42-1452.543.5
Yoon et al[11]Margin width12.112.42.870.7-4.93.040.2-4.9
Xiao et al[12]95/5/096.5/3.5/04.22+/-2.054.3+/-1.49
Sposito et al[13]151598/2/095/5/02.61-6.52.21-8.55637
Cheung et al[14]Age100/0/096.6/3.4/031.2-53.51.5-8.5
Ryu et al[15]11.9143.91.1-174.91-14.53040
Rhu et al[16]37.7/0/037.1/0/03.1+/-5.73.1+/-1.756.658.8
Guro et al[17]Cirrhosis, tumor size95/2.4/2.488/9.9/7.24.1+/-2.46.3+/-3.8
El-Gendi et al[18]100/0/0100/0/03.3+/-0.573.40.596068
Inoue et al[19]89/11/0100/0/02.52.61213
Kim et al[20]9.382.82.82523
Deng et al[21]Procedure type100/0/0100/0/02.52.810.216.6
Wu et al[22]3.50.9-12.53.50.8-11.338.441.9
Tsai et al[23]Procedure magnitude, tumor size93/7/098/2/03.9+/-2.67.2+/-5.3
Di Sandro et al[24]87/13/084/16/02.52-3.02.51.8-3.329.329.3
Li et al[25]Tumor size4+/-25.7+/-31730
Kim et al[26]10.412.83+/-2.13.2+/-3.1422.227.8
Chen et al[27]6.96.97.3+/-3.47.6+/-4.23732
Untereiner et al[28]64/0/073/0/032.1-4.932.3-5
Yoon et al[29]ASA class, medical disease13.61466.8/0/065.4/0/02.831.282.91.3114.315.7
Peng et al[30]94/6/091/9/04.82-8.55.52-8.53030
Yamamoto et al[31]88/22/084/16/01.71.2-4.220.7-9.9
Lee et al[32]90/10/091/9/02.57-14.52.61.1-14.58.68.6
Navarro et al[33]3.58.53.38.151.251.2
Delvecchio et al[34]97/3/098/2/043.0-1671.5-14
Ho et al[35]Hepatitis C carrier status margin width100/0/092/8/03.52-543-528.930